RLU/CO value | N and % women (Ntot = 594) | N and % CIN2+ (Ntot = 162) | Risk for CIN2+ (%) | N and % CIN3+ (Ntot = 114) | Risk for CIN3+ (%) |
---|---|---|---|---|---|
RLU/CO < 0.4 | 253 (42.6) | 8 (4.9) | 3.2 | 2 (1.8) | 0.8 |
0.4 ≤ RLU/CO < 0.7 | 18 (3.0) | 1 (0.6) | 5.6 | 1 (0.9) | 5.6 |
0.7 ≤ RLU/CO < 1.0 | 12 (2.0) | 1 (0.6) | 8.3 | 1 (0.9) | 8.3 |
1.0 ≤ RLU/CO ≤ 2.0 | 15 (2.5) | 1 (0.6) | 6.7 | 1 (0.9) | 6.7 |
2.0 < RLU/CO ≤ 2.5 | 8 (1.3) | 3 (1.9) | 37.5 | 2 (1.8) | 25.0 |
2.5 < RLU/CO ≤ 4.0 | 11 (1.9) | 3 (1.9) | 27.3 | 2 (1.8) | 18.2 |
4.0 < RLU/CO ≤ 10.0 | 26 (4.4) | 7 (4.3) | 26.9 | 6 (5.3) | 23.1 |
10.0 < RLU/CO ≤ 100 | 112 (18.9) | 48 (29.6) | 42.9 | 33 (28.9) | 29.5 |
100 < RLU/CO ≤ 1000 | 105 (17.7) | 68 (42.0) | 64.8 | 53 (46.5) | 50.5 |
1000 < RLU/CO | 34 (5.7) | 22 (13.6) | 64.7 | 13 (11.4) | 38.2 |
RLU/CO value I | N and % women (Ntot = 594) |
---|---|
283 (47.6) | |
23 (3.9) | |
288 (48.5) |